XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML
Product details
Registration number: SIN16115P
Classification: Prescription Only
Active ingredients: Omalizumab
Strength: 75mg/0.5ml
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: R03DX05
HSA approval date: 4 March 2021
Manufacturer(s):
- Vetter Pharma-Fertigung GmbH & Co. KG
- Novartis Pharma Stein AG
- Vetter Pharma-Fertigung GmbH & Co. KG (Inspection for visual defects and Secondary packager)
Manufacturing country/countries: SWITZERLAND; GERMANY
What are the HSA registration number and classification for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16115P
Classification: Prescription Only
What active ingredients and strength are recorded for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Omalizumab
Strength: 75mg/0.5ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Vetter Pharma-Fertigung GmbH & Co. KG
- Novartis Pharma Stein AG
- Vetter Pharma-Fertigung GmbH & Co. KG (Inspection for visual defects and Secondary packager)
Manufacturing country/countries: SWITZERLAND; GERMANY
Where can I look up XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16115P or the exact product name XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML. The general register link does not preselect this product.
What are the source dates for this XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 75MG/0.5ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16115P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)